Status:

NOT_YET_RECRUITING

Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

HVMN Inc

KETONE-IQ

Conditions:

Healthy Participants

Sleep

Eligibility:

All Genders

18-50 years

Phase:

PHASE1

Brief Summary

Ketones are molecules generated by the body during the metabolism of fat. Exogenous ketones (EK) are substances that can raise the level of ketones in the circulation without changing diet. In this re...

Detailed Description

There is growing interest leveraging ketone metabolism for human health and performance. Exogenous ketones (EK) are substances that directly increase circulating ketones in the body without requiring ...

Eligibility Criteria

Inclusion

  • Adults aged 18-50 years old with a BMI of 18 - 30 kg/m\^2

Exclusion

  • No concomitant sleep disorder (e.g. sleep apnea, insomnia, restless leg syndrome, narcolepsy, idiopathic hypersomnia). If there is no known diagnosis of sleep apnea, a STOP-BANG score of 5 or higher is an exclusion.
  • No current daytime respiratory impairment such as uncontrolled asthma, or uncontrolled Chronic Obstructive Pulmonary Disease (COPD), pneumonia, interstitial lung disease.
  • No known history of chronic renal disease or diabetes (type 1 or type 2).
  • No use of supplemental oxygen.
  • Cannot be on a low carbohydrate (\<130 g carbohydrate/day) or ketogenic diet, intermittent fasting, or consuming exogenous ketones
  • Cannot be pregnancy or breastfeeding
  • Cannot be on medications: acetazolamide or Sodium-glucose cotransporter-2 (SGLT2) inhibitor (10), daily opioid use.
  • K-BREATHE: no history of claustrophobia or panic disorder
  • Frequent alcohol intake (more than 1 drink per day on average, or \> 10 drinks per week).

Key Trial Info

Start Date :

January 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2028

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT07224074

Start Date

January 1 2026

End Date

January 1 2028

Last Update

November 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins Bayview

Baltimore, Maryland, United States, 21224